ORION THERAPEUTICS

We are a biotechnology company that ensures the clinical success of early-stage RNA therapy and vaccine development programs.

Our Mission

We provide a multifunctional lipid nanoparticle (LNP) formulation and process that is safe and effective for nucleic acid drug applications
Our patented delivery system incorporates lipids and lipopeptides to help package RNA drug payloads and facilitate cellular entry in diseased tissues
Our nanoscale delivery system can be modified with disease-specific ligands or antibodies to combine targeted biodistribution and enhanced cellular entry at disease site

Perform proof-of-concept studies that validate RNA drug platforms for our clients
Our #1 priority is to continuously increase the asset value of our pharmaceutical partners

Our team is comprised of leading experts in pharmaceutical development of gene therapies, clinical research of non-viral delivery of nucleic acid, and vascular surgeons
Our patented delivery system has been validated for use in vascular disease along with cancer vaccines, CAR-T cell therapy, and liver applications.
Our delivery system has been shown to produce nanoscale delivery systems with high quality critical quality attributes (e.g. size, PDI, EE%, etc.) for a multitude of different nucleic acid payloads

Our Mission